BR9912816A - Therapeutic composition based on flavonoids, intended for use in the treatment of tumors by cytotoxic agents - Google Patents
Therapeutic composition based on flavonoids, intended for use in the treatment of tumors by cytotoxic agentsInfo
- Publication number
- BR9912816A BR9912816A BR9912816-0A BR9912816A BR9912816A BR 9912816 A BR9912816 A BR 9912816A BR 9912816 A BR9912816 A BR 9912816A BR 9912816 A BR9912816 A BR 9912816A
- Authority
- BR
- Brazil
- Prior art keywords
- tumors
- treatment
- intended
- flavonoids
- cytotoxic agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Patente de Invenção: <B>"COMPOSIçãO TERAPêUTICA à BASE DE FLAVONóIDES, TENCIONADA PARA USO NO TRATAMENTO DE TUMORES POR AGENTES CITOTóXICOS"<D>. A presente invenção refere-se a composição tendo uma atividade sobre a proliferação de células clonogênicas em tumores e compreendendo uma quantidade terapeuticamente eficaz de um flavonóide, em particular um composto selecionado entre os compostos de fórmula (I) em que; R~ 1~, R~ 2~, R~ 3~ e R~ 4~, R~ 5~ e R~ 6~ são conforme definidos na reivindicação 2. A composição referida é planejada para uso no tratamento de tumores com agentes citotóxicos.Invention Patent: <B> "THERAPEUTIC COMPOSITION BASED ON FLAVONOIDS, INTENDED FOR USE IN THE TREATMENT OF TUMORS BY CYTOXOTIC AGENTS" <D>. The present invention relates to the composition having an activity on the proliferation of clonogenic cells in tumors and comprising a therapeutically effective amount of a flavonoid, in particular a compound selected from the compounds of formula (I) in which; R ~ 1 ~, R ~ 2 ~, R ~ 3 ~ and R ~ 4 ~, R ~ 5 ~ and R ~ 6 ~ are as defined in claim 2. The said composition is intended for use in the treatment of tumors with cytotoxic agents .
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9809058A FR2781153B1 (en) | 1998-07-15 | 1998-07-15 | FLAVONOID-BASED THERAPEUTIC COMPOSITION FOR USE IN THE TREATMENT OF TUMORS WITH CYTOTOXIC AGENTS |
PCT/FR1999/001714 WO2000003706A1 (en) | 1998-07-15 | 1999-07-13 | Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9912816A true BR9912816A (en) | 2001-05-08 |
Family
ID=9528648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9912816-0A BR9912816A (en) | 1998-07-15 | 1999-07-13 | Therapeutic composition based on flavonoids, intended for use in the treatment of tumors by cytotoxic agents |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1096930A1 (en) |
JP (1) | JP2002520356A (en) |
KR (1) | KR20020003349A (en) |
CN (1) | CN1139384C (en) |
AU (1) | AU4789099A (en) |
BR (1) | BR9912816A (en) |
CA (1) | CA2337179A1 (en) |
EA (1) | EA200100140A1 (en) |
FR (1) | FR2781153B1 (en) |
IL (1) | IL140588A0 (en) |
WO (1) | WO2000003706A1 (en) |
ZA (1) | ZA200100239B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002069949A2 (en) * | 2001-03-06 | 2002-09-12 | Prendergast Patrick T | Combination therapy for reduction of toxycity of chemotherapeutic agents |
EP1808172A3 (en) * | 2002-03-06 | 2010-05-26 | Activephyto Technologies Limited | Botanical extract compositions and methods of use |
AU2003217982A1 (en) * | 2002-03-06 | 2003-09-22 | The Medical Research And Education Trust | Botanical extract compositions with anti-cancer or phytoestrogenic activity comprising wogonin, isoliquiritigenin and/or coumestrol |
US20030229136A1 (en) | 2002-04-18 | 2003-12-11 | Nurulain Zaveri | Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents |
CN1679539A (en) * | 2005-01-20 | 2005-10-12 | 吴一心 | Synergic medicinal composition for preventing from tumor |
CA2600797A1 (en) * | 2005-03-11 | 2006-09-21 | The Regents Of The University Of Michigan | Chromen-4-one inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
GB0808974D0 (en) * | 2008-05-16 | 2008-06-25 | Veritron Ltd | Plant extract and its therapeutic use |
US9808477B2 (en) * | 2015-07-29 | 2017-11-07 | Macau University Of Science And Technology | Use of nobiletin in cancer treatment |
US9808439B2 (en) * | 2015-07-29 | 2017-11-07 | Macau University Of Science And Technology | Use of tangeretin in cancer treatment |
JP6775226B2 (en) * | 2016-06-30 | 2020-10-28 | 国立大学法人広島大学 | Anti-cancer drug action enhancer and anti-cancer drug kit equipped with it |
CN106562954A (en) * | 2016-11-11 | 2017-04-19 | 黄冈师范学院 | Application of (demethylated) polymethoxylated flavones and paclitaxel drugs in preparation of drugs for treating non-small cell lung cancer |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0617304B2 (en) * | 1982-09-09 | 1994-03-09 | 理化学研究所 | Anti-cancer drug |
JPS5959627A (en) * | 1982-09-27 | 1984-04-05 | Tatsuo Miyoshi | Carcinostatic agent |
JPS60199817A (en) * | 1984-03-23 | 1985-10-09 | Rikagaku Kenkyusho | Carcinostatic agent |
JPS632925A (en) * | 1986-06-23 | 1988-01-07 | Nippon Kayaku Co Ltd | C-kinase inhibitor and anti-tumor agent |
FR2633182B1 (en) * | 1988-06-23 | 1993-07-23 | Beljanski Mirko | ANTI-CANCER PHARMACEUTICAL COMPOSITION AND METHOD OF USING THE INVENTION |
JPH04103532A (en) * | 1990-08-24 | 1992-04-06 | Tatsuo Miyoshi | Carcinostatic agent |
JPH04103529A (en) * | 1990-08-24 | 1992-04-06 | Tatsuo Miyoshi | Carcinostatic agent |
JP2514500B2 (en) * | 1991-09-14 | 1996-07-10 | 呉羽化学工業株式会社 | Multidrug resistance inhibitor and expression inhibitor |
EP0642793A4 (en) * | 1992-05-11 | 1995-03-29 | Tsumura & Co. | Apoptosis inducer. |
WO1996031206A2 (en) * | 1995-04-07 | 1996-10-10 | Warner-Lambert Company | Flavones and coumarins as agents for the treatment of atherosclerosis |
DE29719198U1 (en) * | 1997-10-29 | 1998-04-23 | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke, 14558 Bergholz-Rehbrücke | Flavono / flavonoid preparation |
-
1998
- 1998-07-15 FR FR9809058A patent/FR2781153B1/en not_active Expired - Fee Related
-
1999
- 1999-07-13 KR KR1020017000478A patent/KR20020003349A/en not_active Application Discontinuation
- 1999-07-13 AU AU47890/99A patent/AU4789099A/en not_active Abandoned
- 1999-07-13 CA CA002337179A patent/CA2337179A1/en not_active Abandoned
- 1999-07-13 JP JP2000559841A patent/JP2002520356A/en active Pending
- 1999-07-13 BR BR9912816-0A patent/BR9912816A/en not_active IP Right Cessation
- 1999-07-13 EA EA200100140A patent/EA200100140A1/en unknown
- 1999-07-13 EP EP99931342A patent/EP1096930A1/en not_active Withdrawn
- 1999-07-13 WO PCT/FR1999/001714 patent/WO2000003706A1/en not_active Application Discontinuation
- 1999-07-13 CN CNB998098353A patent/CN1139384C/en not_active Expired - Fee Related
- 1999-07-13 IL IL14058899A patent/IL140588A0/en unknown
-
2001
- 2001-01-09 ZA ZA200100239A patent/ZA200100239B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU4789099A (en) | 2000-02-07 |
JP2002520356A (en) | 2002-07-09 |
CN1139384C (en) | 2004-02-25 |
EA200100140A1 (en) | 2001-06-25 |
FR2781153B1 (en) | 2001-08-03 |
ZA200100239B (en) | 2002-01-09 |
IL140588A0 (en) | 2002-02-10 |
KR20020003349A (en) | 2002-01-12 |
CN1313765A (en) | 2001-09-19 |
CA2337179A1 (en) | 2000-01-27 |
WO2000003706A1 (en) | 2000-01-27 |
EP1096930A1 (en) | 2001-05-09 |
FR2781153A1 (en) | 2000-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911482A (en) | Compound, pharmaceutical composition, use of the compound, and, processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
ECSP003682A (en) | COMPOUNDS FOR THE TREATMENT OF THE ISCHEMIA | |
BR9911488A (en) | Compound, use of it, pharmaceutical composition, and processes for the treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound | |
BR9912073A (en) | Pharmaceutical compositions comprising 2-quinolones | |
BR9714082A (en) | Compound, use thereof, pharmaceutical composition, and, processes for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound. | |
BR9907270A (en) | Compound, pharmaceutical composition, use of a compound, and, processes for the treatment or prophylaxis of inflammatory diseases, for example, asthma or copd, and for the preparation of a compound | |
AR023423A1 (en) | ADAMANTAN DERIVATIVES, PROCEDURES FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION, PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITION, AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF MEDICINES | |
BR9914638A (en) | Compound, method for its preparation, pharmaceutical composition, use of a compound, and method for the treatment of a disorder or disease in the body of a living animal | |
BR0209127A (en) | compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds | |
BR0214343A (en) | 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1 | |
BR0008840A (en) | Camptothecin derivatives having antitumor activity | |
BRPI0111639B8 (en) | use of an immunostimulatory oligodeoxynucleic acid molecule and pharmaceutical composition. | |
ES2161085T3 (en) | FORMULATIONS CONTAINING OXALIPLATIN. | |
BRPI0311323B8 (en) | sglt2 c-aryl glycoside inhibitor compound, pharmaceutical composition and combination | |
BR0010716A (en) | Phenyl compounds substituted with immunosuppressive activity and pharmaceutical compositions | |
BR0110767A (en) | Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity | |
BR0308429A (en) | Monocyclic Aroylpyridinones as Anti-Inflammatory Agents | |
ES2149305T3 (en) | SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USE PROCEDURES. | |
BR9912816A (en) | Therapeutic composition based on flavonoids, intended for use in the treatment of tumors by cytotoxic agents | |
BR0113590A (en) | 7-oxopyridopyrimidines | |
BR9916422A (en) | Antiprotozoal saponins | |
AR018162A1 (en) | SUBSTITUTED PIRROLS, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF SUCH PHARMACEUTICAL COMPOSITION | |
BR0209128A (en) | Compounds, pharmaceutical compositions, methods for treating pain, methods for modulating a pharmacological response and uses of compounds | |
BR0208405A (en) | Cyan-substituted dihydropyrimine compounds and their use to treat disease | |
TR200000737T2 (en) | Substituted chroma derivatives. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A, 8A E 9A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1911 DE 21/08/2007. |